Рынок рецептурных дерматологических препаратов вырастет до 54,27 млрд долларов к 2030 году

09-09-2026 10:23 AM CET | Health & Medicine Press release from: The Business Research Company The prescription dermatological drugs sector is positioned for significant expansion in the coming years, driven by increasing health concerns and evolving treatment options. As skin-related conditions become more prevalent and awareness grows, this market is set to witness meaningful advancements and rising demand for specialized medications. Let's explore the market's size projections, key players, emerging trends, and segmentation to understand its future trajectory. Steady Growth Outlook for the Prescription Dermatological Drugs Market Size Through 2030 The prescription dermatological drugs market is anticipated to experience robust growth, reaching a valuation of $54.27 billion by 2030. This increase corresponds to a compound annual growth rate of 6.3%. Several factors underpin this positive outlook, including the rising prevalence of psoriasis, escalating demand for advanced dermatological treatments, a growing elderly population affected by skin disorders, expansion of specialty dermatology care, and heightened awareness surrounding skin health. Key trends forecasted to influence the market include a rise in chronic skin conditions, increased use of prescription-strength topical medications, wider adoption of combination therapies, emphasis on long-term management of skin diseases, and a growing preference for targeted dermatological drugs. Download a free sample of the prescription dermatological drugs market report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21262&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR Key Factors Fueling Demand in the Prescription Dermatological Drugs Market A notable rise in chronic skin ailments such as psoriasis and dermatitis is significantly boosting the need for effective pharmaceutical interventions. Patients and healthcare providers alike are turning toward prescription medications that offer stronger and more specialized treatment options compared to over-the-counter alternatives. Additionally, the increasing focus on personalized, combination therapeutic regimens is shaping how dermatological disorders are managed. This shift supports more precise disease control and improved patient outcomes, facilitating ongoing demand for new and innovative drug classes within this market. View the full prescription dermatological drugs market report: https://www.thebusinessresearchcompany.com/report/prescription-dermatological-drugs-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR Top Players Leading the Prescription Dermatological Drugs Industry The prescription dermatological drugs market features a range of prominent pharmaceutical companies, including Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Healthcare Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., and DermBiont Inc. A notable recent development occurred in October 2024 when Organon & Co., a US-based pharmaceutical firm, acquired Dermavant Sciences Ltd. for $1.2 billion. This strategic acquisition aims to strengthen Organon's dermatology portfolio by broadening its offerings of innovative therapies for chronic skin diseases like prurigo nodularis and psoriasis. Dermavant Sciences specializes in immunodermatology, focusing on advanced therapeutic solutions. Emerging Trends Shaping the Prescription Dermatological Drugs Market Pharmaceutical companies are increasingly concentrating on new treatment options targeting prurigo nodularis, particularly involving interleukin-31 (IL-31) receptor antagonists. These biologic therapies block the IL-31 signaling pathway, which is a key driver of intense itching and inflammation associated with this condition. For example, in December 2024, Galderma, a dermatology company headquartered in Switzerland, received approval from the US FDA for Nemluvio (nemolizumab). This fully human monoclonal antibody inhibits the IL-31 receptor alpha and has demonstrated significant reductions in itch severity and nodule burden in several pivotal clinical studies. Administered once every four weeks through subcutaneous injection, Nemluvio offers a convenient treatment schedule that promotes better long-term disease control and patient adherence. Key Segmentation of the Global Prescription Dermatological Drugs Market This market is segmented according to drug class, indication, and distribution channel. The categories include: 1) Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, and Other Drug Classes 2) Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, and Other Indications 3) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others Subcategories further refine these groups: - Corticosteroids: Topical, Oral, Injectable - Retinoids: Topical, Oral - Calcineurin Inhibitors: Topical, Oral - Antifungal Agents: Topical, Oral - Antibiotics: Topical, Oral - Other Drug Classes: Immunosuppressants, Phototherapy Agents Together, these segments provide a comprehensive overview of the diverse therapeutic options and distribution methods driving the prescription dermatological drugs market forward. Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. Reach out to us: The Business Research Company: https://www.thebusinessresearchcompany.com/, Americas +1 310-496-7795, Europe +44 7882 955267, Asia & Others +44 7882 955267 & +91 8897263534, Email us at [email protected]. Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company, Twitter: https://twitter.com/tbrc_info, YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Learn More About The Business Research Company With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making. This release was published on openPR. Permanent link to this press release: Copy Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release. You can edit or delete your press release Emerging Growth Trends Driving the Expansion of the Prescription Dermatological Drugs Market here News-ID: 4625843 • Views: … 09-11-2026 | IT, New Media & Software The Business Research Company Case Management Market Analysis Highlights Growth To $13.46 Billion By 2030 At 1 … The case management industry is undergoing rapid expansion, driven by technological advancements and evolving business practices. As organizations seek more efficient ways to handle cases and ensure compliance, the market for case management solutions continues to grow at an impressive pace. Let's explore the current market size, influential factors fueling growth, key players, emerging trends, and the main segments shaping this dynamic sector. Projected Market Size and Growth Trajectory of the … 09-11-2026 | IT, New Media & Software The Business Research Company Carbon Capture And Storage Technology Market Outlook Highlights Strategic Opport … The carbon capture and storage technology sector has been gaining significant traction as the world intensifies efforts to reduce carbon emissions. With evolving regulations and technological advancements, this market is set to expand rapidly over the coming years. Here's an overview of the market size, key drivers, major players, notable trends, and the main segments shaping its future. Projected Market Value and Growth Trajectory of the Carbon Capture and Storage Technology … 09-11-2026 | IT, New Media & Software The Business Research Company Call Center Outsourcing Market Report Evaluates Growth Drivers, Challenges And M … The call center outsourcing sector has witnessed significant expansion in recent years, driven by a mix of evolving customer service needs and technological progress. This report explores the market's current size, key players, growth drivers, and emerging trends that are shaping its future outlook. Call Center Outsourcing Market Size and Growth Outlook Through 2030 The market for call center outsourcing has seen robust development recently. It is forecasted to rise … 09-11-2026 | IT, New Media & Software The Business Research Company BYOD Security Market Trends Support A 37.2% CAGR Outlook Through The Forecast Pe … The BYOD security market has been experiencing rapid growth due to the increasing reliance on personal devices for work and the need to protect sensitive enterprise data. As companies adapt to flexible working environments and rising cybersecurity threats, the demand for robust BYOD security solutions continues to escalate. Let's explore the current market size, key drivers, leading players, emerging trends, and major segments shaping this fast-evolving industry. Forecasted Growth and Market … All 5 Releases 09-06-2024 | Health & Medicine SkyQuest Technology Group Injectable Drug Delivery Market Injectable Drug Delivery Market Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming … 09-06-2024 | IT, New Media & Software Report Prime Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De … Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic … 07-22-2024 | Health & Medicine KuicK Research Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric … Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550 … 02-04-2019 | Business, Economy, Finances, B … marketstudyreport.com Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application … Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug … 01-04-2019 | Health & Medicine marketreportsworld How much Diabetes Drug Market Impact Worldwide Medical Drug Industry? Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes … 07-11-2017 | Health & Medicine Kuick Resarch Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023 For Report Sample Contact: [email protected] or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase …